Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. (Record no. 18858402)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02019 a2200601 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515171302.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200906s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1539-2864 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1097/IAE.0b013e318188501f |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gregori, Ninel Z |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20090625 |
| 245 00 - TITLE STATEMENT | |
| Title | Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Retina (Philadelphia, Pa.) |
| Date of publication, distribution, etc. | Oct 2008 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1325-37 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bevacizumab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Injections |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Macula Lutea |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Macular Edema |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retinal Vein Occlusion |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retrospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Time Factors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tomography, Optical Coherence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vascular Endothelial Growth Factor A |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Visual Acuity |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vitreous Body |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gaitan, Jaime |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rosenfeld, Philip J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Puliafito, Carmen A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Feuer, William |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Flynn, Harry W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berrocal, Audina M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Al-Attar, Luma |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dubovy, Sander |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smiddy, William E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schwartz, Stephen G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lee, Wen-Hsiang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Murray, Timothy G |
| 773 0# - HOST ITEM ENTRY | |
| Title | Retina (Philadelphia, Pa.) |
| Related parts | vol. 28 |
| -- | no. 9 |
| -- | p. 1325-37 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1097/IAE.0b013e318188501f">https://doi.org/10.1097/IAE.0b013e318188501f</a> |
| Public note | Available from publisher's website |
No items available.